Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FIBCD1 antisense RNA 1 (FIBCD1-AS1)
- Target
- FIBCD1-AS1
- Molecular classification
- Long non-coding RNA, natural antisense transcript
01
Overview
FIBCD1 antisense RNA 1 (FIBCD1-AS1) is a long non-coding RNA (lncRNA) that is transcribed from the locus antisense to the FIBCD1 gene on human chromosome 9q34.12. As a natural antisense RNA, FIBCD1-AS1 is classified as a non-protein-coding transcript. The specific biological function of FIBCD1-AS1 has not been elucidated in published literature. It may, like other antisense lncRNAs, participate in the regulation of its sense gene (FIBCD1), potentially through mechanisms such as transcriptional interference, RNA-RNA duplex formation, or epigenetic modification, but this is not directly demonstrated for FIBCD1-AS1 itself. There is no evidence that FIBCD1-AS1 is currently a therapeutic target, nor are there drugs, safety concerns, biomarkers, or established roles in disease specifically attributed to this RNA transcript.\n\nIf you are seeking information on the *protein-coding* gene **FIBCD1**, which encodes an endocytic receptor involved in glycosaminoglycan binding and nervous system development, that is a separate molecule and not the focus of "FIBCD1-AS1".
- Other names
- FIBCD1-AS1long non-coding RNA FIBCD1-AS1lncRNA FIBCD1-AS1
02
Biological functions
Putative regulation of FIBCD1 gene expressionregulation of gene expression at epigenetic/transcriptional/post-transcriptional levels (based on known roles for antisense lncRNAs generally; direct evidence specific to FIBCD1-AS1 is currently lacking)
03
Disease associations
Unknown for FIBCD1-AS1 specifically; however, some lncRNAs/antisense RNAs have been implicated in cancer and other diseasesNo disease association is directly established for FIBCD1-AS1 in the current search results
Beyond the preview
Go deeper on FIBCD1 antisense RNA 1 (FIBCD1-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FIBCD1 antisense RNA 1 (FIBCD1-AS1).